Global Fruquintinib Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Fruquintinib market size was valued at US$ 479 million in 2025 and is forecast to a readjusted size of US$ 1379 million by 2032 with a CAGR of 14.6% during review period.
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
This report is a detailed and comprehensive analysis for global Fruquintinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fruquintinib market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fruquintinib market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Fruquintinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fruquintinib, with price, sales quantity, revenue, and global market share of Fruquintinib from 2021 to 2026.
Chapter 3, the Fruquintinib competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fruquintinib breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fruquintinib market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fruquintinib.
Chapter 14 and 15, to describe Fruquintinib sales channel, distributors, customers, research findings and conclusion.
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
This report is a detailed and comprehensive analysis for global Fruquintinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fruquintinib market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fruquintinib market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Fruquintinib
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fruquintinib market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 1 mg capsule
- 5 mg capsule
- Hospital
- Retail
- Online
- Metastatic Colorectal Cancer (mCRC)
- Inhibit Tumor Angiogenesis
- Others
- Hutchison China MediTech Limited
- Takeda Pharmaceutical Company Limited
- Sichuan Qingmu Pharmaceutical
- Shanghai Boyi Chemical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Fruquintinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fruquintinib, with price, sales quantity, revenue, and global market share of Fruquintinib from 2021 to 2026.
Chapter 3, the Fruquintinib competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fruquintinib breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fruquintinib market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fruquintinib.
Chapter 14 and 15, to describe Fruquintinib sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Fruquintinib Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 1 mg capsule
1.3.3 5 mg capsule
1.4 Market Analysis by Sales Channels
1.4.1 Overview: Global Fruquintinib Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Retail
1.4.4 Online
1.5 Market Analysis by Application
1.5.1 Overview: Global Fruquintinib Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Metastatic Colorectal Cancer (mCRC)
1.5.3 Inhibit Tumor Angiogenesis
1.5.4 Others
1.6 Global Fruquintinib Market Size & Forecast
1.6.1 Global Fruquintinib Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Fruquintinib Sales Quantity (2021-2032)
1.6.3 Global Fruquintinib Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Hutchison China MediTech Limited
2.1.1 Hutchison China MediTech Limited Details
2.1.2 Hutchison China MediTech Limited Major Business
2.1.3 Hutchison China MediTech Limited Fruquintinib Product and Services
2.1.4 Hutchison China MediTech Limited Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Hutchison China MediTech Limited Recent Developments/Updates
2.2 Takeda Pharmaceutical Company Limited
2.2.1 Takeda Pharmaceutical Company Limited Details
2.2.2 Takeda Pharmaceutical Company Limited Major Business
2.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
2.2.4 Takeda Pharmaceutical Company Limited Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.3 Sichuan Qingmu Pharmaceutical
2.3.1 Sichuan Qingmu Pharmaceutical Details
2.3.2 Sichuan Qingmu Pharmaceutical Major Business
2.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
2.3.4 Sichuan Qingmu Pharmaceutical Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sichuan Qingmu Pharmaceutical Recent Developments/Updates
2.4 Shanghai Boyi Chemical
2.4.1 Shanghai Boyi Chemical Details
2.4.2 Shanghai Boyi Chemical Major Business
2.4.3 Shanghai Boyi Chemical Fruquintinib Product and Services
2.4.4 Shanghai Boyi Chemical Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shanghai Boyi Chemical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FRUQUINTINIB BY MANUFACTURER
3.1 Global Fruquintinib Sales Quantity by Manufacturer (2021-2026)
3.2 Global Fruquintinib Revenue by Manufacturer (2021-2026)
3.3 Global Fruquintinib Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Fruquintinib by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Fruquintinib Manufacturer Market Share in 2025
3.4.3 Top 6 Fruquintinib Manufacturer Market Share in 2025
3.5 Fruquintinib Market: Overall Company Footprint Analysis
3.5.1 Fruquintinib Market: Region Footprint
3.5.2 Fruquintinib Market: Company Product Type Footprint
3.5.3 Fruquintinib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Fruquintinib Market Size by Region
4.1.1 Global Fruquintinib Sales Quantity by Region (2021-2032)
4.1.2 Global Fruquintinib Consumption Value by Region (2021-2032)
4.1.3 Global Fruquintinib Average Price by Region (2021-2032)
4.2 North America Fruquintinib Consumption Value (2021-2032)
4.3 Europe Fruquintinib Consumption Value (2021-2032)
4.4 Asia-Pacific Fruquintinib Consumption Value (2021-2032)
4.5 South America Fruquintinib Consumption Value (2021-2032)
4.6 Middle East & Africa Fruquintinib Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Fruquintinib Sales Quantity by Type (2021-2032)
5.2 Global Fruquintinib Consumption Value by Type (2021-2032)
5.3 Global Fruquintinib Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Fruquintinib Sales Quantity by Application (2021-2032)
6.2 Global Fruquintinib Consumption Value by Application (2021-2032)
6.3 Global Fruquintinib Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Fruquintinib Sales Quantity by Type (2021-2032)
7.2 North America Fruquintinib Sales Quantity by Application (2021-2032)
7.3 North America Fruquintinib Market Size by Country
7.3.1 North America Fruquintinib Sales Quantity by Country (2021-2032)
7.3.2 North America Fruquintinib Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Fruquintinib Sales Quantity by Type (2021-2032)
8.2 Europe Fruquintinib Sales Quantity by Application (2021-2032)
8.3 Europe Fruquintinib Market Size by Country
8.3.1 Europe Fruquintinib Sales Quantity by Country (2021-2032)
8.3.2 Europe Fruquintinib Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Fruquintinib Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Fruquintinib Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Fruquintinib Market Size by Region
9.3.1 Asia-Pacific Fruquintinib Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Fruquintinib Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Fruquintinib Sales Quantity by Type (2021-2032)
10.2 South America Fruquintinib Sales Quantity by Application (2021-2032)
10.3 South America Fruquintinib Market Size by Country
10.3.1 South America Fruquintinib Sales Quantity by Country (2021-2032)
10.3.2 South America Fruquintinib Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Fruquintinib Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Fruquintinib Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Fruquintinib Market Size by Country
11.3.1 Middle East & Africa Fruquintinib Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Fruquintinib Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Fruquintinib Market Drivers
12.2 Fruquintinib Market Restraints
12.3 Fruquintinib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Fruquintinib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fruquintinib
13.3 Fruquintinib Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fruquintinib Typical Distributors
14.3 Fruquintinib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Fruquintinib Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 1 mg capsule
1.3.3 5 mg capsule
1.4 Market Analysis by Sales Channels
1.4.1 Overview: Global Fruquintinib Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Retail
1.4.4 Online
1.5 Market Analysis by Application
1.5.1 Overview: Global Fruquintinib Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Metastatic Colorectal Cancer (mCRC)
1.5.3 Inhibit Tumor Angiogenesis
1.5.4 Others
1.6 Global Fruquintinib Market Size & Forecast
1.6.1 Global Fruquintinib Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Fruquintinib Sales Quantity (2021-2032)
1.6.3 Global Fruquintinib Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Hutchison China MediTech Limited
2.1.1 Hutchison China MediTech Limited Details
2.1.2 Hutchison China MediTech Limited Major Business
2.1.3 Hutchison China MediTech Limited Fruquintinib Product and Services
2.1.4 Hutchison China MediTech Limited Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Hutchison China MediTech Limited Recent Developments/Updates
2.2 Takeda Pharmaceutical Company Limited
2.2.1 Takeda Pharmaceutical Company Limited Details
2.2.2 Takeda Pharmaceutical Company Limited Major Business
2.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
2.2.4 Takeda Pharmaceutical Company Limited Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.3 Sichuan Qingmu Pharmaceutical
2.3.1 Sichuan Qingmu Pharmaceutical Details
2.3.2 Sichuan Qingmu Pharmaceutical Major Business
2.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
2.3.4 Sichuan Qingmu Pharmaceutical Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sichuan Qingmu Pharmaceutical Recent Developments/Updates
2.4 Shanghai Boyi Chemical
2.4.1 Shanghai Boyi Chemical Details
2.4.2 Shanghai Boyi Chemical Major Business
2.4.3 Shanghai Boyi Chemical Fruquintinib Product and Services
2.4.4 Shanghai Boyi Chemical Fruquintinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shanghai Boyi Chemical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FRUQUINTINIB BY MANUFACTURER
3.1 Global Fruquintinib Sales Quantity by Manufacturer (2021-2026)
3.2 Global Fruquintinib Revenue by Manufacturer (2021-2026)
3.3 Global Fruquintinib Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Fruquintinib by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Fruquintinib Manufacturer Market Share in 2025
3.4.3 Top 6 Fruquintinib Manufacturer Market Share in 2025
3.5 Fruquintinib Market: Overall Company Footprint Analysis
3.5.1 Fruquintinib Market: Region Footprint
3.5.2 Fruquintinib Market: Company Product Type Footprint
3.5.3 Fruquintinib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Fruquintinib Market Size by Region
4.1.1 Global Fruquintinib Sales Quantity by Region (2021-2032)
4.1.2 Global Fruquintinib Consumption Value by Region (2021-2032)
4.1.3 Global Fruquintinib Average Price by Region (2021-2032)
4.2 North America Fruquintinib Consumption Value (2021-2032)
4.3 Europe Fruquintinib Consumption Value (2021-2032)
4.4 Asia-Pacific Fruquintinib Consumption Value (2021-2032)
4.5 South America Fruquintinib Consumption Value (2021-2032)
4.6 Middle East & Africa Fruquintinib Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Fruquintinib Sales Quantity by Type (2021-2032)
5.2 Global Fruquintinib Consumption Value by Type (2021-2032)
5.3 Global Fruquintinib Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Fruquintinib Sales Quantity by Application (2021-2032)
6.2 Global Fruquintinib Consumption Value by Application (2021-2032)
6.3 Global Fruquintinib Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Fruquintinib Sales Quantity by Type (2021-2032)
7.2 North America Fruquintinib Sales Quantity by Application (2021-2032)
7.3 North America Fruquintinib Market Size by Country
7.3.1 North America Fruquintinib Sales Quantity by Country (2021-2032)
7.3.2 North America Fruquintinib Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Fruquintinib Sales Quantity by Type (2021-2032)
8.2 Europe Fruquintinib Sales Quantity by Application (2021-2032)
8.3 Europe Fruquintinib Market Size by Country
8.3.1 Europe Fruquintinib Sales Quantity by Country (2021-2032)
8.3.2 Europe Fruquintinib Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Fruquintinib Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Fruquintinib Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Fruquintinib Market Size by Region
9.3.1 Asia-Pacific Fruquintinib Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Fruquintinib Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Fruquintinib Sales Quantity by Type (2021-2032)
10.2 South America Fruquintinib Sales Quantity by Application (2021-2032)
10.3 South America Fruquintinib Market Size by Country
10.3.1 South America Fruquintinib Sales Quantity by Country (2021-2032)
10.3.2 South America Fruquintinib Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Fruquintinib Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Fruquintinib Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Fruquintinib Market Size by Country
11.3.1 Middle East & Africa Fruquintinib Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Fruquintinib Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Fruquintinib Market Drivers
12.2 Fruquintinib Market Restraints
12.3 Fruquintinib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Fruquintinib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fruquintinib
13.3 Fruquintinib Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fruquintinib Typical Distributors
14.3 Fruquintinib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Fruquintinib Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Fruquintinib Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 3. Global Fruquintinib Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Hutchison China MediTech Limited Basic Information, Manufacturing Base and Competitors
Table 5. Hutchison China MediTech Limited Major Business
Table 6. Hutchison China MediTech Limited Fruquintinib Product and Services
Table 7. Hutchison China MediTech Limited Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Hutchison China MediTech Limited Recent Developments/Updates
Table 9. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 10. Takeda Pharmaceutical Company Limited Major Business
Table 11. Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
Table 12. Takeda Pharmaceutical Company Limited Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 14. Sichuan Qingmu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Sichuan Qingmu Pharmaceutical Major Business
Table 16. Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
Table 17. Sichuan Qingmu Pharmaceutical Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Sichuan Qingmu Pharmaceutical Recent Developments/Updates
Table 19. Shanghai Boyi Chemical Basic Information, Manufacturing Base and Competitors
Table 20. Shanghai Boyi Chemical Major Business
Table 21. Shanghai Boyi Chemical Fruquintinib Product and Services
Table 22. Shanghai Boyi Chemical Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Shanghai Boyi Chemical Recent Developments/Updates
Table 24. Global Fruquintinib Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 25. Global Fruquintinib Revenue by Manufacturer (2021-2026) & (USD Million)
Table 26. Global Fruquintinib Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 27. Market Position of Manufacturers in Fruquintinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 28. Head Office and Fruquintinib Production Site of Key Manufacturer
Table 29. Fruquintinib Market: Company Product Type Footprint
Table 30. Fruquintinib Market: Company Product Application Footprint
Table 31. Fruquintinib New Market Entrants and Barriers to Market Entry
Table 32. Fruquintinib Mergers, Acquisition, Agreements, and Collaborations
Table 33. Global Fruquintinib Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 34. Global Fruquintinib Sales Quantity by Region (2021-2026) & (Units)
Table 35. Global Fruquintinib Sales Quantity by Region (2027-2032) & (Units)
Table 36. Global Fruquintinib Consumption Value by Region (2021-2026) & (USD Million)
Table 37. Global Fruquintinib Consumption Value by Region (2027-2032) & (USD Million)
Table 38. Global Fruquintinib Average Price by Region (2021-2026) & (US$/Unit)
Table 39. Global Fruquintinib Average Price by Region (2027-2032) & (US$/Unit)
Table 40. Global Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 41. Global Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 42. Global Fruquintinib Consumption Value by Type (2021-2026) & (USD Million)
Table 43. Global Fruquintinib Consumption Value by Type (2027-2032) & (USD Million)
Table 44. Global Fruquintinib Average Price by Type (2021-2026) & (US$/Unit)
Table 45. Global Fruquintinib Average Price by Type (2027-2032) & (US$/Unit)
Table 46. Global Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 47. Global Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 48. Global Fruquintinib Consumption Value by Application (2021-2026) & (USD Million)
Table 49. Global Fruquintinib Consumption Value by Application (2027-2032) & (USD Million)
Table 50. Global Fruquintinib Average Price by Application (2021-2026) & (US$/Unit)
Table 51. Global Fruquintinib Average Price by Application (2027-2032) & (US$/Unit)
Table 52. North America Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 53. North America Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 54. North America Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 55. North America Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 56. North America Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 57. North America Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 58. North America Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 59. North America Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 60. Europe Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 61. Europe Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 62. Europe Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 63. Europe Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 64. Europe Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 65. Europe Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 66. Europe Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 67. Europe Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 68. Asia-Pacific Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 69. Asia-Pacific Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 70. Asia-Pacific Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 71. Asia-Pacific Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 72. Asia-Pacific Fruquintinib Sales Quantity by Region (2021-2026) & (Units)
Table 73. Asia-Pacific Fruquintinib Sales Quantity by Region (2027-2032) & (Units)
Table 74. Asia-Pacific Fruquintinib Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Fruquintinib Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 77. South America Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 78. South America Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 79. South America Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 80. South America Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 81. South America Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 82. South America Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 85. Middle East & Africa Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 86. Middle East & Africa Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 87. Middle East & Africa Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 88. Middle East & Africa Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 89. Middle East & Africa Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 90. Middle East & Africa Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Middle East & Africa Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Fruquintinib Raw Material
Table 93. Key Manufacturers of Fruquintinib Raw Materials
Table 94. Fruquintinib Typical Distributors
Table 95. Fruquintinib Typical Customers
Table 1. Global Fruquintinib Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Fruquintinib Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 3. Global Fruquintinib Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Hutchison China MediTech Limited Basic Information, Manufacturing Base and Competitors
Table 5. Hutchison China MediTech Limited Major Business
Table 6. Hutchison China MediTech Limited Fruquintinib Product and Services
Table 7. Hutchison China MediTech Limited Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Hutchison China MediTech Limited Recent Developments/Updates
Table 9. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 10. Takeda Pharmaceutical Company Limited Major Business
Table 11. Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
Table 12. Takeda Pharmaceutical Company Limited Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 14. Sichuan Qingmu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Sichuan Qingmu Pharmaceutical Major Business
Table 16. Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
Table 17. Sichuan Qingmu Pharmaceutical Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Sichuan Qingmu Pharmaceutical Recent Developments/Updates
Table 19. Shanghai Boyi Chemical Basic Information, Manufacturing Base and Competitors
Table 20. Shanghai Boyi Chemical Major Business
Table 21. Shanghai Boyi Chemical Fruquintinib Product and Services
Table 22. Shanghai Boyi Chemical Fruquintinib Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Shanghai Boyi Chemical Recent Developments/Updates
Table 24. Global Fruquintinib Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 25. Global Fruquintinib Revenue by Manufacturer (2021-2026) & (USD Million)
Table 26. Global Fruquintinib Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 27. Market Position of Manufacturers in Fruquintinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 28. Head Office and Fruquintinib Production Site of Key Manufacturer
Table 29. Fruquintinib Market: Company Product Type Footprint
Table 30. Fruquintinib Market: Company Product Application Footprint
Table 31. Fruquintinib New Market Entrants and Barriers to Market Entry
Table 32. Fruquintinib Mergers, Acquisition, Agreements, and Collaborations
Table 33. Global Fruquintinib Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 34. Global Fruquintinib Sales Quantity by Region (2021-2026) & (Units)
Table 35. Global Fruquintinib Sales Quantity by Region (2027-2032) & (Units)
Table 36. Global Fruquintinib Consumption Value by Region (2021-2026) & (USD Million)
Table 37. Global Fruquintinib Consumption Value by Region (2027-2032) & (USD Million)
Table 38. Global Fruquintinib Average Price by Region (2021-2026) & (US$/Unit)
Table 39. Global Fruquintinib Average Price by Region (2027-2032) & (US$/Unit)
Table 40. Global Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 41. Global Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 42. Global Fruquintinib Consumption Value by Type (2021-2026) & (USD Million)
Table 43. Global Fruquintinib Consumption Value by Type (2027-2032) & (USD Million)
Table 44. Global Fruquintinib Average Price by Type (2021-2026) & (US$/Unit)
Table 45. Global Fruquintinib Average Price by Type (2027-2032) & (US$/Unit)
Table 46. Global Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 47. Global Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 48. Global Fruquintinib Consumption Value by Application (2021-2026) & (USD Million)
Table 49. Global Fruquintinib Consumption Value by Application (2027-2032) & (USD Million)
Table 50. Global Fruquintinib Average Price by Application (2021-2026) & (US$/Unit)
Table 51. Global Fruquintinib Average Price by Application (2027-2032) & (US$/Unit)
Table 52. North America Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 53. North America Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 54. North America Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 55. North America Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 56. North America Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 57. North America Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 58. North America Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 59. North America Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 60. Europe Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 61. Europe Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 62. Europe Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 63. Europe Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 64. Europe Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 65. Europe Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 66. Europe Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 67. Europe Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 68. Asia-Pacific Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 69. Asia-Pacific Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 70. Asia-Pacific Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 71. Asia-Pacific Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 72. Asia-Pacific Fruquintinib Sales Quantity by Region (2021-2026) & (Units)
Table 73. Asia-Pacific Fruquintinib Sales Quantity by Region (2027-2032) & (Units)
Table 74. Asia-Pacific Fruquintinib Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Fruquintinib Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 77. South America Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 78. South America Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 79. South America Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 80. South America Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 81. South America Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 82. South America Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Fruquintinib Sales Quantity by Type (2021-2026) & (Units)
Table 85. Middle East & Africa Fruquintinib Sales Quantity by Type (2027-2032) & (Units)
Table 86. Middle East & Africa Fruquintinib Sales Quantity by Application (2021-2026) & (Units)
Table 87. Middle East & Africa Fruquintinib Sales Quantity by Application (2027-2032) & (Units)
Table 88. Middle East & Africa Fruquintinib Sales Quantity by Country (2021-2026) & (Units)
Table 89. Middle East & Africa Fruquintinib Sales Quantity by Country (2027-2032) & (Units)
Table 90. Middle East & Africa Fruquintinib Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Middle East & Africa Fruquintinib Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Fruquintinib Raw Material
Table 93. Key Manufacturers of Fruquintinib Raw Materials
Table 94. Fruquintinib Typical Distributors
Table 95. Fruquintinib Typical Customers
LIST OF FIGURES
Figure 1. Fruquintinib Picture
Figure 2. Global Fruquintinib Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Fruquintinib Revenue Market Share by Type in 2025
Figure 4. 1 mg capsule Examples
Figure 5. 5 mg capsule Examples
Figure 6. Global Fruquintinib Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Fruquintinib Revenue Market Share by Sales Channels in 2025
Figure 8. Hospital Examples
Figure 9. Retail Examples
Figure 10. Online Examples
Figure 11.Tablet Examples
Figure 12. Capsule Examples
Figure 13. Global Fruquintinib Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Fruquintinib Revenue Market Share by Application in 2025
Figure 15. Metastatic Colorectal Cancer (mCRC) Examples
Figure 16. Inhibit Tumor Angiogenesis Examples
Figure 17. Others Examples
Figure 18. Global Fruquintinib Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Fruquintinib Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Fruquintinib Sales Quantity (2021-2032) & (Units)
Figure 21. Global Fruquintinib Price (2021-2032) & (US$/Unit)
Figure 22. Global Fruquintinib Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Fruquintinib Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Fruquintinib by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Fruquintinib Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Fruquintinib Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Fruquintinib Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Fruquintinib Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Fruquintinib Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Fruquintinib Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Fruquintinib Revenue Market Share by Application (2021-2032)
Figure 39. Global Fruquintinib Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 52. France Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Fruquintinib Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Fruquintinib Consumption Value Market Share by Region (2021-2032)
Figure 60. China Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 63. India Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 80. Fruquintinib Market Drivers
Figure 81. Fruquintinib Market Restraints
Figure 82. Fruquintinib Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Fruquintinib in 2025
Figure 85. Manufacturing Process Analysis of Fruquintinib
Figure 86. Fruquintinib Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Figure 1. Fruquintinib Picture
Figure 2. Global Fruquintinib Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Fruquintinib Revenue Market Share by Type in 2025
Figure 4. 1 mg capsule Examples
Figure 5. 5 mg capsule Examples
Figure 6. Global Fruquintinib Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Fruquintinib Revenue Market Share by Sales Channels in 2025
Figure 8. Hospital Examples
Figure 9. Retail Examples
Figure 10. Online Examples
Figure 11.Tablet Examples
Figure 12. Capsule Examples
Figure 13. Global Fruquintinib Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Fruquintinib Revenue Market Share by Application in 2025
Figure 15. Metastatic Colorectal Cancer (mCRC) Examples
Figure 16. Inhibit Tumor Angiogenesis Examples
Figure 17. Others Examples
Figure 18. Global Fruquintinib Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Fruquintinib Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Fruquintinib Sales Quantity (2021-2032) & (Units)
Figure 21. Global Fruquintinib Price (2021-2032) & (US$/Unit)
Figure 22. Global Fruquintinib Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Fruquintinib Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Fruquintinib by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Fruquintinib Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Fruquintinib Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Fruquintinib Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Fruquintinib Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Fruquintinib Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Fruquintinib Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Fruquintinib Revenue Market Share by Application (2021-2032)
Figure 39. Global Fruquintinib Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 52. France Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Fruquintinib Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Fruquintinib Consumption Value Market Share by Region (2021-2032)
Figure 60. China Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 63. India Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Fruquintinib Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Fruquintinib Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Fruquintinib Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Fruquintinib Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Fruquintinib Consumption Value (2021-2032) & (USD Million)
Figure 80. Fruquintinib Market Drivers
Figure 81. Fruquintinib Market Restraints
Figure 82. Fruquintinib Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Fruquintinib in 2025
Figure 85. Manufacturing Process Analysis of Fruquintinib
Figure 86. Fruquintinib Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
